0001127602-20-001938.txt : 20200117 0001127602-20-001938.hdr.sgml : 20200117 20200117163143 ACCESSION NUMBER: 0001127602-20-001938 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200115 FILED AS OF DATE: 20200117 DATE AS OF CHANGE: 20200117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MERLO LARRY J CENTRAL INDEX KEY: 0001194413 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 20533971 MAIL ADDRESS: STREET 1: ONE CVS DR CITY: WOONSOCKET STATE: RI ZIP: 02895 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-01-15 0000064803 CVS HEALTH Corp CVS 0001194413 MERLO LARRY J ONE CVS DRIVE WOONSOCKET RI 02895- 1 1 President and CEO Common Stock 2020-01-15 4 M 0 314713 54.53 A 703496.9407 D Common Stock 2020-01-15 4 S 0 266476 74.79 D 437020.9407 D Common Stock 391070.4564 I By Trust As Beneficiary Common Stock (restricted) 81879 D ESOP Common Stock 7208.3869 I By ESOP Stock Unit 665529.4676 D Stock Option 54.53 2020-01-15 4 M 0 314713 0 D 2014-04-01 2020-04-01 Common Stock 314713 0 D Phantom Stock Credits 1.00 Common Stock 5158.5846 5158.5846 D Stock Option 74.29 2015-04-01 2021-04-01 Common Stock 335697 335697 D Stock Option 102.26 2016-04-01 2022-04-01 Common Stock 273929 273929 D Stock Option 104.82 2017-04-01 2023-04-01 Common Stock 286787 286787 D Stock Option 78.05 2018-04-03 2024-04-03 Common Stock 338105 338105 D Stock Option 62.21 2019-04-01 2025-04-01 Common Stock 394091 394091 D Stock Option 54.19 2020-04-01 2029-04-01 Common Stock 545419 545419 D All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the Reporting Person retaining all remaining shares. Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $73.99 and $75.55 per share. Option became exercisable in four equal annual installments, commencing 4/1/2014. Each share credit is equivalent to one share; 1-for-1 conversion. Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. Option became exercisable in four equal annual installments, commencing 4/1/2015. Option became exercisable in four equal annual installments, commencing 4/1/2016. Option became exercisable in four equal annual installments, commencing 4/1/2017. Option became exercisable in four equal annual installments, commencing 4/3/2018. Option became exercisable in four equal annual installments, commencing 4/1/2019. Option becomes exercisable in four equal annual installments, commencing 4/1/2020. Larry J. Merlo 2020-01-17